Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
德康醫療
DXCM
5
Workday
WDAY
(FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 43.34%2.68億 | -33.58%4,700.4萬 | 18.56%8,144.1萬 | 47.55%6,656.1萬 | 3,276.75%7,263.4萬 | -27.21%1.87億 | 6.04%7,076.4萬 | -4.37%6,869萬 | -31.55%4,511.2萬 | -95.87%215.1萬 |
營業收入 | 43.34%2.68億 | -33.58%4,700.4萬 | 18.56%8,144.1萬 | 47.55%6,656.1萬 | 3,276.75%7,263.4萬 | -27.21%1.87億 | 6.04%7,076.4萬 | -4.37%6,869萬 | -31.55%4,511.2萬 | -95.87%215.1萬 |
主營業務成本 | 45.22%2.68億 | -29.84%4,904.4萬 | 13.73%7,756.3萬 | 58.42%6,836.7萬 | 2,025.54%7,324.6萬 | -29.52%1.85億 | 3.00%6,990萬 | -6.49%6,819.8萬 | -34.73%4,315.6萬 | -93.75%344.6萬 |
毛利 | -128.76%-58萬 | -336.11%-204萬 | 688.21%387.8萬 | -192.33%-180.6萬 | 52.74%-61.2萬 | 136.44%201.7萬 | 176.33%86.4萬 | 144.57%49.2萬 | 1,014.02%195.6萬 | 58.02%-129.5萬 |
營業費用 | 1.06%3,983.6萬 | 16.42%1,143.6萬 | -14.09%775萬 | 21.08%1,180萬 | -18.27%885萬 | 36.56%3,941.8萬 | 29.92%982.3萬 | 38.98%902.1萬 | 30.43%974.6萬 | 47.48%1,082.8萬 |
銷售和管理費用 | 1.06%3,983.6萬 | 16.42%1,143.6萬 | -14.09%775萬 | 21.08%1,180萬 | -18.27%885萬 | 37.41%3,941.8萬 | 30.63%982.3萬 | 40.10%902.1萬 | 31.33%974.6萬 | 48.21%1,082.8萬 |
營業利潤 | -8.06%-4,041.6萬 | -50.42%-1,347.6萬 | 54.60%-387.2萬 | -74.66%-1,360.6萬 | 21.95%-946.2萬 | -8.72%-3,740.1萬 | -3.06%-895.9萬 | -12.30%-852.9萬 | -1.35%-779萬 | -16.27%-1,212.3萬 |
淨非營業利息收入(費用) | 8.50%-5,931.9萬 | 3.21%-1,528萬 | 16.22%-1,501.4萬 | 7.95%-1,520.1萬 | 5.39%-1,382.4萬 | -67.71%-6,483.2萬 | -24.10%-1,578.6萬 | -81.70%-1,792.1萬 | -102.03%-1,651.4萬 | -84.93%-1,461.1萬 |
利息費用 | -9.35%5,285.6萬 | -2.04%1,370.9萬 | -18.95%1,336.3萬 | -11.87%1,338.1萬 | -1.89%1,240.3萬 | 86.32%5,830.8萬 | 32.57%1,399.4萬 | 100.34%1,648.8萬 | 136.00%1,518.4萬 | 108.10%1,264.2萬 |
其他財務費用 | -0.94%646.3萬 | -12.33%157.1萬 | 15.21%165.1萬 | 36.84%182萬 | -27.83%142.1萬 | -11.39%652.4萬 | -17.19%179.2萬 | -12.25%143.3萬 | -23.56%133萬 | 7.83%196.9萬 |
其他淨收入(費用) | -34.23%136.6萬 | 233.33%19萬 | -33.89%122.5萬 | -80.22%1.8萬 | -188.16%-6.7萬 | 106.17%207.7萬 | 32.56%5.7萬 | 103.75%185.3萬 | -99.42%9.1萬 | 85.37%7.6萬 |
其他非經營收入(費用) | -34.23%136.6萬 | 233.33%19萬 | -33.89%122.5萬 | -80.22%1.8萬 | -188.16%-6.7萬 | -85.52%207.7萬 | 32.56%5.7萬 | 92,550.00%185.3萬 | -99.36%9.1萬 | 85.37%7.6萬 |
稅前利潤 | 1.78%-9,836.9萬 | -15.71%-2,856.6萬 | 28.20%-1,766.1萬 | -18.90%-2,878.9萬 | 12.40%-2,335.3萬 | 6.14%-1億 | -15.53%-2,468.8萬 | 63.20%-2,459.7萬 | -11,653.88%-2,421.3萬 | -45.78%-2,665.8萬 |
所得稅 | 79.84%-1,083.2萬 | -1,740.45%-1,236.9萬 | 100.50%27.4萬 | -63.88%38.5萬 | 454.03%87.8萬 | -5,203.13%-5,373.6萬 | -27.50%75.4萬 | -1,843,700.00%-5,530.8萬 | 35,433.33%106.6萬 | -3,642.86%-24.8萬 |
除稅後利潤 | -88.58%-8,753.7萬 | 36.34%-1,619.7萬 | -158.40%-1,793.5萬 | -15.41%-2,917.4萬 | 8.25%-2,423.1萬 | 56.92%-4,642萬 | -13.53%-2,544.2萬 | 145.94%3,071.1萬 | -11,995.22%-2,527.9萬 | -44.36%-2,641萬 |
持續經營利潤 | -88.58%-8,753.7萬 | 36.34%-1,619.7萬 | -158.40%-1,793.5萬 | -15.41%-2,917.4萬 | 8.25%-2,423.1萬 | 56.92%-4,642萬 | -13.53%-2,544.2萬 | 145.94%3,071.1萬 | -11,995.22%-2,527.9萬 | -44.36%-2,641萬 |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | -88.58%-8,753.7萬 | 36.34%-1,619.7萬 | -158.40%-1,793.5萬 | -15.41%-2,917.4萬 | 8.25%-2,423.1萬 | 56.92%-4,642萬 | -13.53%-2,544.2萬 | 145.94%3,071.1萬 | -11,995.22%-2,527.9萬 | -44.36%-2,641萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | -88.58%-8,753.7萬 | 36.34%-1,619.7萬 | -158.40%-1,793.5萬 | -15.41%-2,917.4萬 | 8.25%-2,423.1萬 | 56.92%-4,642萬 | -13.53%-2,544.2萬 | 145.94%3,071.1萬 | -11,995.22%-2,527.9萬 | -44.36%-2,641萬 |
基本每股收益 | -56.56%-1.91 | 43.75%-0.36 | -148.10%-0.38 | 2.94%-0.66 | 20.55%-0.58 | 60.90%-1.22 | -1.59%-0.64 | 141.15%0.79 | -6,700.00%-0.68 | -35.19%-0.73 |
稀釋每股收益 | -56.56%-1.91 | 43.75%-0.36 | -152.05%-0.38 | 2.94%-0.66 | 20.55%-0.58 | 60.90%-1.22 | -1.59%-0.64 | 138.02%0.73 | -6,700.00%-0.68 | -35.19%-0.73 |
每股派息 | ||||||||||
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
審計意見 | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- | -- |